Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Carolyn Mulroney

    TitleAssociate Clinical Professor
    SchoolUniversity of California, San Diego
    Address9500 Gilman Drive #0960
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Clinical Trials
      Co-Investigator on several clinical trials in the Blood and Marrow Transplantation Division: BMTCTN 0402, IRB # 101006, A Phase III Randomized, Multicenter Trial comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as a Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA- Matched, Related Peripheral Blood Stem Cell transplantation.

      Education and Training
      B.A. - University of Pennsylvania, Philadelphia, PA - 1978-1982
      M.D. - Johns Hopkins University School of Medicine - 1982-1986
      Research Fellowship - American Academy of Allergy and Immunology, John Hopkins University School of Medicine Division of Immunology, Durham, Baltimore, Maryland - 1986
      Intern in Internal Medicine - Duke University School of Medicine, Durham, North Carolina - 1986-1987
      Hematology Fellowship - University of Washington, Seattle, Washington - 1990-1992
      Hematology Oncology Fellow - University of California, San Francisco, CA - 1992

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wang WS, Ma JD, Nelson SH, Revta C, Buckholz GT, Mulroney C, Roeland EJ. Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation. J Oncol Pract. 2017 Sep; 13(9):e721-e728. PMID: 28644706.
        View in: PubMed
      2. Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R. Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol. 2017 06; 1. PMID: 28681041.
        View in: PubMed
      3. Li K, Johnson RL, Li S, Thorson JA, Mulroney C, Dell'Aquila ML, Wang HY. Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. Int J Clin Exp Pathol. 2014; 7(8):5221-31. PMID: 25197401; PMCID: PMC4152091.
      4. Dimsdale JE, Ball ED, Carrier E, Wallace M, Holman P, Mulroney C, Shaikh F, Natarajan L. Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. Support Care Cancer. 2011 Dec; 19(12):2015-20. PMID: 21116652; PMCID: PMC3204044.
      5. Mulroney C, Gl├╝ck S, Ho AD. The use of photodynamic therapy in bone marrow purging. Semin Oncol. 1994 Dec; 21(6 Suppl 15):24-7. PMID: 7992104.
        View in: PubMed